echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > EJPS: Researchers have developed new anti-inflammatory drugs.

    EJPS: Researchers have developed new anti-inflammatory drugs.

    • Last Update: 2020-09-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    SEPTEMBER 11, 2020 /--- In a recent study, Halle-Wittenberg, a researcher at Martin LutherAne University's Institute of Pharmaceuticals, et al., developed a method for producing controlled-quality anti-inflammatory drugs.
    because the body does not recognize it as a foreign body, they have an advantage over anti-inflammatory drugs such as ibuprofen or bichlorofenic acid.
    results were published in the European Journal of Pharmaceutical Sciences.
    to imitate nature, " explains Professor Karsten Mäder of the MLU School of Pharmacy.
    ", these new anti-inflammatory substances are naturally present in the body, such as the inner surface of cells.
    when cells die, phosphatidylserine (PS) and other components in the cell membrane are exposed, which provides a signal to the phagocytosis target.
    PS also ensures that the inflammatory response is suppressed.
    another ingredient called phospholipid phosphatidyl glycelin (PG) also ensures that there is no excessive inflammatory response.
    team has now prepared both substances, so they could be used as drugs to treat infarction, arthritis and psoriasis.
    (Photo Source: www.pixabay.com) From a medical point of view, both phospholipids are of concern to researchers because the body cannot identify them as foreign, meaning fewer side effects can be expected.
    U.S. study, PS is particularly effective for inflammation after a heart attack.
    "But preparation is a complex process, " says Mäder.
    Halle's team has now developed a simpler and cheaper production process.
    phospholipids to form small particles smaller than ten nanometers in size.
    makes them easy to filter asepticly.
    have also been shown to be harmless to cells and blood components.
    , PG particles produced in this way showed reduced inflammatory activity of phagocytosphages under laboratory conditions.
    show that phospholipids work well in anti-inflammatory treatments, " said Mäder, a research team.
    , however, some clinical trials are needed before natural anti-inflammatory substances can be used in humans.
    (bioon.com) Source: Nature as model: Researchers develop novel anti-ingy substance Source: Miriam Elisabeth Klein et al, Phosphatidylserine (PS) and phosphatidylglycerol (PG) enriched mixed micelles (MM): A new nano-drug delivery system with anti-appy potential?, European Journal of Pharmaceutical Sciences (2020). DOI: 10.1016/j.ejps.2020.105451.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.